Who We Are

LEADERSHIP

Richard H. Shinn, Ph.D.

Founder & CEO, AIBrain
Richard founded AIBrain in Palo Alto, California in 2013, to build autonomous AI solutions as well as best-selling AI courses such as AutoML. Together with AIBrain, he started Augmented Brain Labs in Lausanne, Switzerland in 2022, to provide game-changing AI solutions to professional sports clubs in Football (Soccer) and Ice Hockey.
In 2023, he also founded TuringSign, a global certification authority in Lausanne, Switzerland. Already securing the websites of leading enterprises with high-assurance certificates, TuringSign will launch its global SSL beta via e-commerce in 2025, expanding its security solutions to a broader customer base worldwide.
Richard received his Ph.D. in artificial intelligence from Georgia Institute of Technology, his M.S. in Computer Science from Pennsylvania State University, and his B.S. in Applied Mathematics from Seoul National University.

Soeren Maerki

Vice President, TuringSign Global SA
Soeren’s professional passion is to shape the future of eSecurity and Digital Trust. As one of the key architects behind the global SSL/TLS brand TuringSign, he drives new business development and strategic initiatives to deliver cutting-edge digital security solutions to clients worldwide. A passionate advocate for technological innovation, Soeren also co-authored AIBrain’s best-selling AI course AutoML for Beginners, making Artificial Intelligence easily accessible to everyone.
Prior to his current position, he served on the board of directors of a publicly listed Korean cybersecurity company, and held various roles in management consulting and global sales. A Swiss citizen, Soeren holds a Master in International Finance and a Bachelor in Economics from Yonsei University.

Stephen Williams, Ph.D.

Chief Product Advisor, Life Sciences
Stephen Williams, Ph.D., led discovery biology and pre-clinical development for radiopharmaceuticals at DuPont / New England Nuclear, resulting in the discovery and development of Cardiolite® and Neurolite®. He also led strategic product planning at DuPont Merck Pharmaceuticals. He was a Medical Director in new product planning for CNS diseases at Bristol-Myers Squibb. As the head of business development, he executed a successful IPO at Progenitor, a biotechnology company. Steve received his B.S. in Biology from the University of North Carolina at Chapel Hill and his Ph.D. in Pharmacology from Duke University.

Milan Lee, J.D.

Chief Strategy Officer
Milan, a high-tech start-up veteran and long-time AI enthusiast, is committed to empowering intellectual innovation. As AIBrain’s Chief Strategy Officer, she works to build synergism amongst investors, developers, and consumers, allowing for creative solutions to global problems. Milan has leveraged the power of cutting-edge technology since launching her first successful startup, Netizen Communications Inc., in 1996. As the founder and CEO, she grew $1M of venture capital funding into a $10M company in just three years. Over the next two decades, she served as founder and CEO of uBond.com Inc., the Venture Academy Foundation, and her latest passion project, WiseMe.Ai. Milan holds a Doctor of Jurisprudence degree from San Francisco Law School, and BA in Economics with a Philosophy minor from U.C. Davis.

Bernhard Egger, Ph.D.

Academic Advisor
Bernhard Egger is a professor at the Department of Computer Science and Engineering at Seoul National University (SNU). He received a combined B.Sc./M.Sc. degree in Computer Science from the Swiss Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich, ETHZ) in 2001 and a PhD degree in Computer Science from SNU in 2008. After obtaining his PhD degree, he spent three years as a senior research engineer at Samsung’s central research facility, the Samsung Advanced Institute of Technology (SAIT) before re-joining SNU in March of 2011.